Glycerol Phenylbutyrate Oral Liquid — FDA Drug Shortage

To Be Discontinued — Amgen Inc.

The FDA lists a drug shortage record for Glycerol Phenylbutyrate Oral Liquid from Amgen Inc. with status To Be Discontinued. The shortage was first posted on Sep 1, 2026.

Shortage details

Status
To Be Discontinued
Company
Amgen Inc.
Package NDC
75987-050-06
Presentation
RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06)
Initial Posting
Sep 1, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.